Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Clinical CAR-T Cell and Oncolytic Virotherapy for Cancer Treatment

Molecular Therapy(2020)10.1016/j.ymthe.2020.10.023Source: DataRank Database

Clinical CAR-T Cell and Oncolytic Virotherapy for Cancer Treatment is a research paper published in Molecular Therapy (2020). On theSindex it has a DataRank of 0. It has been cited 85 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access85 citations

Download PDF

Cite:

Linked data & code

eudract nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 3.80)OA: bronzeTopics (31)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Mary K. McKenna ORCID,Amanda Rosewell Shaw ORCID,Masataka Suzuki ORCID,Norihiro Watanabe ORCID

Live enrichment

PubMed:33130314 PMC:PMC7854303 OpenAlex:https://openalex.org/W3095088217

National Institutes of Health

Grant: 5T32HL092332-17

NCI NIH HHS

Grant: P50 CA126752

NCI NIH HHS

Grant: P30 CA125123

NHLBI NIH HHS

Grant: T32 HL092332

National Heart, Lung, and Blood Institute

Baylor College of Medicine

FWCI

3.80

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

bronzeLicense: http://creativecommons.org/licenses/by-nc-nd/4.0/

journalhttp://www.cell.com/article/S1525001620305943/pdf

publisherhttp://www.cell.com/article/S1525001620305943/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1525001620305943?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1525001620305943?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ymthe.2020.10.023

Fields of Study

CAR-T cell therapy researchVirus-based gene therapy researchNanowire Synthesis and Applications

MeSH Terms

Clinical Studies as TopicReceptors, Chimeric AntigenCombined Modality TherapyGenetic VectorsHumansNeoplasmsReceptors, Antigen, T-CellT-LymphocytesGenetic TherapyImmunotherapy, AdoptiveTreatment OutcomeOncolytic VirotherapyOncolytic Viruses

Keywords

Oncolytic virusChimeric antigen receptorVirotherapyImmunotherapyCancer immunotherapyMedicineCancerCancer researchTumor microenvironmentT cellAntigenImmunologyImmune systemTumor cellsInternal medicine

Sustainable Development Goals

SDG 0: Good health and well-being